Stock Research for gwph


Featured Broker: Ally Invest

Get the due diligence for another stock.


gwph Stock Chart & Research Data

The gwph chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the gwph chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


gwph Due diligence Resources & Stock Charts

The gwph stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View gwph Detailed Price Forecast - CNN Money CNN View gwph Detailed Summary - Google Finance
Yahoo View gwph Detailed Summary - Yahoo! Finance Zacks View gwph Stock Research & Analysis -

Stock Analysis

TradeIdeas View gwph Trends & Analysis - Trade-Ideas Barrons View gwph Major Holders - Barrons
NASDAQ View gwph Call Transcripts - NASDAQ Seeking View gwph Breaking News & Analysis - Seeking Alpha
Spotlight View gwph Annual Report - OTC Report View gwph OTC Short Report -
TradeKing View gwph Fundamentals - TradeKing Charts View gwph SEC Filings - Bar Chart
WSJ View Historical Prices for gwph - The WSJ Morningstar View Performance/Total Return for gwph - Morningstar
MarketWatch View the Analyst Estimates for gwph - MarketWatch CNBC View the Earnings History for gwph - CNBC
StockMarketWatch View the gwph Earnings - StockMarketWatch MacroAxis View gwph Buy or Sell Recommendations - MacroAxis
Bullish View the gwph Bullish Patterns - American Bulls Short Pains View gwph Short Pain Metrics -

Social Media Mentions

StockTwits View gwph Stock Mentions - StockTwits PennyStocks View gwph Stock Mentions - PennyStockTweets
Twitter View gwph Stock Mentions - Twitter Invest Hub View gwph Investment Forum News - Investor Hub
Yahoo View gwph Stock Mentions - Yahoo! Message Board Seeking Alpha View gwph Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for gwph - Insider Cow View Insider Transactions for gwph - Insider Cow
CNBC View gwph Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for gwph - OTC Markets
Yahoo View Insider Transactions for gwph - Yahoo! Finance NASDAQ View Institutional Holdings for gwph - NASDAQ

Stock Charts

FinViz View gwph Stock Insight & Charts - StockCharts View gwph Investment Charts -
BarChart View gwph Stock Overview & Charts - BarChart Trading View View gwph User Generated Charts - Trading View

Latest Financial News for gwph

GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex
Posted on Tuesday March 31, 2020

GW Pharmaceuticals plc (GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with its U.S. subsidiary Greenwich Biosciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted supplemental New Drug Application (sNDA) for the use of  EPIDIOLEX® (cannabidiol) CV to treat seizures associated with Tuberous Sclerosis Complex (TSC). The PDUFA (Prescription Drug User Fee Act) goal date for completion of the FDA review of the EPIDIOLEX sNDA is July 31, 2020.

Why This Biotech Stock And Its CBD Oil Are Immune To Coronavirus
Posted on Tuesday March 24, 2020

GW Pharmaceuticals and its CBD oil are immune to coronavirus, according to an analyst — prodding GWPH stock to pop Monday and Tuesday. The drug, Epidiolex, treats several forms of epilepsy.

Does GW Pharmaceuticals plc's (NASDAQ:GWPH) CEO Pay Compare Well With Peers?
Posted on Friday March 20, 2020

In 1999 Justin Gover was appointed CEO of GW Pharmaceuticals plc (NASDAQ:GWPH). This report will, first, examine the...

GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC)
Posted on Friday March 13, 2020

LONDON, March 13, 2020 -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and commercialising cannabinoid.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.